The fourth dataset comprised 41, 000 ovarian cancer cases with extensive clinical and treatment information, including metastasis, age, lymph node status, PIK3CA, P53, BRCA, stage, nodal status, histology, tumor size, grade, surgical margins, surgeries, chemotherapy, antihormonal, and other treatments. This evidence concerns the gene TP53 and ovarian carcinoma.